Google
Trusted Resources: News & Events
Latest announcements and gatherings
SCDAA MARAC Position on 2020 School Reopening
July 27, 2020 – Sickle cell disease remains a high-risk condition for severe COVID-19 infection. Registry data show that individuals with sickle cell disease are more vulnerable to death with COVID-19 at all ages, including children.
We recommend that families with children with sickle cell disease follow state and local guidelines regarding the determination of in-person versus distance learning as long as processes are in place to ensure the least possible risk of your child getting infected with COVID-19. If safety measures are not implemented or cannot be enforced, we recommend that schools provide equitable access to high quality education through home-based distance learning. The checklist below should be used to determine if your child’s school has the recommended safety measures in place.
+myBinderRelated Content
-
Sickle Cell Disease Association of America Extends its COVID-19 Emergency FundraiserThe Sickle Cell Disease Association of A...
-
FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDS) for COVID-19[3/19/2020] FDA is aware of news reports...
-
Community Congress Ad Hoc COVID-19 Response Working Group WebinarCommunity Congress Ad Hoc COVID-19 Respo...
-
COVID-19 Update 7: Managing Patients With SCD During COVID-19 Crisis, With Drs. Michaelis & OsunkwoIn this installment, The Hematologist Ed...
-
COVID-19, Sickle Cell Disease, and a Critical NeedWe are facing a global pandemic as cases...
-
Listening to Sickle Cell Patients is Crucial During a CrisisI recently was admitted to the hospital ...
-
COVID-19 Resources for Non-Profit Leaders and the Community | National Organization for Rare DisordersThe health and safety of those with rare...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.